Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$0.768
-0.0320 (-4.00%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.700 $1.03 Friday, 10th May 2024 HOOK stock ended at $0.768. This is 4.00% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.46% from a day low at $0.740 to a day high of $0.81.
90 days $0.605 $1.03
52 weeks $0.410 $2.05

Historical Hookipa Pharma Inc. prices

Date Open High Low Close Volume
Apr 05, 2024 $0.738 $0.755 $0.715 $0.753 513 745
Apr 04, 2024 $0.762 $0.792 $0.743 $0.747 449 883
Apr 03, 2024 $0.760 $0.790 $0.740 $0.769 900 047
Apr 02, 2024 $0.725 $0.760 $0.701 $0.760 720 986
Apr 01, 2024 $0.712 $0.740 $0.711 $0.724 223 459
Mar 28, 2024 $0.726 $0.740 $0.710 $0.712 375 761
Mar 27, 2024 $0.710 $0.730 $0.701 $0.720 415 246
Mar 26, 2024 $0.705 $0.732 $0.701 $0.719 129 216
Mar 25, 2024 $0.725 $0.740 $0.700 $0.703 388 610
Mar 22, 2024 $0.750 $0.750 $0.711 $0.711 601 995
Mar 21, 2024 $0.710 $0.730 $0.710 $0.724 256 082
Mar 20, 2024 $0.735 $0.735 $0.705 $0.713 232 144
Mar 19, 2024 $0.702 $0.737 $0.700 $0.735 478 769
Mar 18, 2024 $0.720 $0.720 $0.680 $0.718 387 132
Mar 15, 2024 $0.683 $0.730 $0.681 $0.719 456 721
Mar 14, 2024 $0.731 $0.740 $0.666 $0.687 528 618
Mar 13, 2024 $0.742 $0.750 $0.711 $0.742 431 898
Mar 12, 2024 $0.790 $0.795 $0.710 $0.735 603 931
Mar 11, 2024 $0.781 $0.791 $0.751 $0.789 317 414
Mar 08, 2024 $0.777 $0.795 $0.750 $0.761 513 806
Mar 07, 2024 $0.796 $0.82 $0.771 $0.777 427 702
Mar 06, 2024 $0.82 $0.82 $0.781 $0.785 250 070
Mar 05, 2024 $0.790 $0.81 $0.750 $0.796 383 753
Mar 04, 2024 $0.80 $0.83 $0.780 $0.81 730 851
Mar 01, 2024 $0.790 $0.80 $0.753 $0.770 298 945
Click to get the best stock tips daily for free!

About Hookipa Pharma Inc.

Hookipa Pharma. HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-2... HOOK Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT